Not finding it? Sign in to also search OpenAlex live.
-
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies2021 Clinical and Translational Science article Immunology and Microbiology Macrophage Migration Inhibitory Factor Open access
Theresa Hildegard Wirtz, Sven Heiko Loosen, Max Schulze‐Hagen, Joao Gorgulho, Jennis Kandler, Markus S. Joerdens, +9 more
13citations -
Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip cultures2022 American Journal of Physiology-Lung Cellular and Molecular Physiology article Engineering 3D Printing in Biomedical Research Open access
Sander van Riet, Annemarie M. van Schadewijk, Padmini P. S. J. Khedoe, Ronald W.A.L. Limpens, Montserrat Bárcena, Jan N Stolk, +2 more
58citations -
Apollo: Phase 3 Randomized Study of Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Meletios Athanasios Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksaç, Eirini Katodritou, +17 more
51citations -
Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis2020 JHEP Reports article Immunology and Microbiology Macrophage Migration Inhibitory Factor Open access
Theresa Hildegard Wirtz, Philipp Alexander Reuken, Christian Jansen, Petra Fischer, Irina Bergmann, Christina Backhaus, +21 more
28citations -
Downregulation of the metalloproteinases ADAM10 or ADAM17 promotes osteoclast differentiation2024 Cell Communication and Signaling article Biochemistry, Genetics and Molecular Biology Bone Metabolism and Diseases Open access
Aaron Babendreyer, Julia Kieselhorst, Cindy Rinkens, A. M. Lyashenko, Stefan Düsterhöft, Holger Jahr, +2 more
10citations -
Safety and Tolerability of AZD0466 As Monotherapy for Patients with Advanced Hematologic Malignancies. Results from a Phase I/II Trial2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Cell death mechanisms and regulation
Shukaib Arslan, Giovanni Marconi, Giovanni Martinelli, Shaun A. Fleming, Antonio Curti, Shira Naomi Dinner, +19 more
5citations -
Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis
Sven Heiko Loosen, Max Schulze‐Hagen, Mihael Vucur, Joao Gorgulho, Pia Paffenholz, Fabian Benz, +9 more
2citations -
MPN with multiple driver clones show distinct patterns of therapy response and progression - “MPN double driver”2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kirsi Marjaana Manz, Tina M. Schnoeder, Francesca Palandri, Filippo Branzanti, Heike Luise Pahl, Martin Grießhammer, +20 more
2citations